TNF Blockers News and Research

RSS
New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Results of study comparing REMICADE to azathioprine for Crohn's disease published

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from efficacy study of CIMZIA in Crohn's disease patients presented

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

Cimzia approved for treating adult patients with rheumatoid arthritis

Cimzia approved for treating adult patients with rheumatoid arthritis

Expert available on recent FDA analysis of TNF blockers

Expert available on recent FDA analysis of TNF blockers

Golimumab shows promise for rheumatoid arthritis

Golimumab shows promise for rheumatoid arthritis

Roche files MabThera as a first-line biologic treatment for rheumatoid arthritis in Europe

Roche files MabThera as a first-line biologic treatment for rheumatoid arthritis in Europe

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Adult stem cells from bone marrow can deliver cancer-killing proteins to tumors

Adult stem cells from bone marrow can deliver cancer-killing proteins to tumors

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

Senior men more likely than women to die after pneumonia

Senior men more likely than women to die after pneumonia

Overexpression of PEA-15 protein shrinks breast cancer tumors

Overexpression of PEA-15 protein shrinks breast cancer tumors

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

Laughter improves health

Laughter improves health

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.